| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha,interleukin-6, soluble interleukin-6 receptor and vascular endothelialgrowth factor in serum and ascitic fluid of patients with severe ovarianhyperstimulation syndrome |
Aboulghar, M.A.;Mansour, R.T.;Serour, G.I.;El Helw, B.A.;Shaarawy, M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
1999-11-01 |
查看 |
| Plasma levels of free vascular endothelial growth factor"1"6"5 (VEGF"1"6"5)are not elevated during gonadotropin stimulation in in vitro fertilization(IVF) patients developing ovarian hyperstimulation syndrome (OHSS): resultsof a prospective cohort study with matched controls |
Enskog, A.;Nilsson, L.;Brannstrom, M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2001-06-01 |
查看 |
| Plasma levels of free vascular endothelial growth factor"1"6"5(VEGF"1"6"5) are not elevated during gonadotropin stimulation in in vitrofertilization (IVF) patients developing ovarian hyperstimulation syndrome(OHSS): results of a prospective cohort study with matched controls |
Enskog, A.;Nilsson, L.;Brannstrom, M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2001-06-01 |
查看 |
| The detrimental role of colloidal volume substitutes in severe ovarianhyperstimulation syndrome: a case report |
Kissler, S.;Neidhardt, B.;Siebzehnrubl, E.;Schmitt, H.;Tschaikowsky, K.;Wildt, L.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2001-11-01 |
查看 |
| The detrimental role of colloidal volume substitutes in severe ovarianhyperstimulation syndrome: a case report |
Kissler, S.;Neidhardt, B.;Siebzehnrubl, E.;Schmitt, H.;Tschaikowsky, K.;Wildt, L.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2001-11-01 |
查看 |
| Prevention and management of ovarian hyperstimulation syndrome |
Mathur, R.;Evbuomwan, I.;Jenkins, J.; |
Current Obstetrics and Gynaecology |
2002-04-01 |
查看 |
| Prevention and management of ovarian hyperstimulation syndrome |
Mathur, R.;Evbuomwan, I.;Jenkins, J.; |
Current Obstetrics and Gynaecology |
2002-04-01 |
查看 |
| Prevention and management of ovarian hyperstimulation syndrome |
Mathur, R.;Evbuomwan, I.;Jenkins, J.; |
Current Obstetrics and Gynaecology |
2002-04-01 |
查看 |
| The effect of withholding gonadotropin (a coasting period) on theoutcome of in vitro fertilization cycles |
Owj, M.;Tehrani Nejad, E.Sh.;Amirchaghmaghi, E.;Ezabadi, Z.;Baghestani, A.R.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2007-07-01 |
查看 |
| The effect of withholding gonadotropin (a coasting period) on theoutcome of in vitro fertilization cycles |
Owj, M.;Tehrani Nejad, E.Sh.;Amirchaghmaghi, E.;Ezabadi, Z.;Baghestani, A.R.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2007-07-01 |
查看 |
| IVF outcome in women with PCOS, PCO and normal ovarian morphology |
Swanton, A.;Storey, L.;McVeigh, E.;Child, T.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2010-03-01 |
查看 |
| Cumulative live birth rates after GnRH-agonist triggering of finaloocyte maturation in patients at risk of OHSS: A prospective, clinicalcohort study |
Griesinger, G.;Berndt, H.;Schultz, L.;Depenbusch, M.;Schultze-Mosgau, A.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2010-04-01 |
查看 |
| The diagnosis and management of ovarian hyperstimulation syndrome |
Shmorgun, D.;Claman, P.;Gysler, M.;Hemmings, R.;Cheung, A.P.;Goodrow, G.J.;Hughes, E.G.;Min, J.K.;Roberts, J.;Senikas, V.;Wong, B.C.M.;Young, D.C.; |
International Journal of Gynecology & Obstetrics |
2012-03-01 |
查看 |
| Can dopamine agonist at a low dose reduce ovarian hyperstimulationsyndrome in women at risk undergoing ICSI treatment cycles? A randomizedcontrolled study |
Shaltout, A.;Shohyab, A.;Youssef, M.A.F.M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2012-12-01 |
查看 |
| Can dopamine agonist at a low dose reduce ovarian hyperstimulationsyndrome in women at risk undergoing ICSI treatment cycles? A randomizedcontrolled study |
Shaltout, A.;Shohyab, A.;Youssef, M.A.F.M.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2012-12-01 |
查看 |
| In vitro fertilisation treatment and factors affecting success |
Huang, J.Y.J.;Rosenwaks, Z.; |
Best Practice & Research in Clinical Obstetrics and Gynaecology |
2012-12-01 |
查看 |
| Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVFcycles in moderate risk patients: randomized study comparing hydroxyethylstarch versus cabergoline and hydroxyethyl starch |
Matorras, R.;Andres, M.;Mendoza, R.;Prieto, B.;Pijoan, J.I.;Exposito, A.; |
European Journal of Obstetrics & Gynecology and Reproductive Biology |
2013-10-01 |
查看 |
| A gonadotropin releasing hormone agonist trigger of ovulation withaggressive luteal phase support for patients at risk of ovarianhyperstimulation syndrome undergoing controlled ovarian hyperstimulation |
Liang, I.T.;Huang, H.Y.;Wu, H.M.;Wang, H.S.;Yu, H.T.;Huang, S.Y.;Chang, C.L.;Soong, Y.K.; |
Taiwanese Journal of Obstetrics and Gynecology |
2015-10-01 |
查看 |
|
|
